Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study

This publication has 24 references indexed in Scilit:

• Diffuse High Intensity PD–L1 Staining in Thymic Epithelial Tumors
  Journal of Thoracic Oncology, 2015
• A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L
  Annals of Oncology, 2014
• Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy
  Journal of Cancer Research and Clinical Oncology, 2014
• Combination Chemotherapy with Carboplatin and Paclitaxel for Advanced Thymic Cancer
  Japanese Journal of Clinical Oncology, 2011
• Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience
  European Journal of Cardio-Thoracic Surgery, 2011
• Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma
  Journal of Clinical Oncology, 2011
• Epidemiology of Thymoma and Associated Malignancies
  Journal of Thoracic Oncology, 2010
• Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma
  Lung Cancer, 2010
• Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies
  International Journal of Cancer, 2003
• Role of staging in prognosis and management of thymoma
  The Annals of Thoracic Surgery, 1991